摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-溴-2-氯苯甲醚 | 50638-47-6

中文名称
4-溴-2-氯苯甲醚
中文别名
2-氯-4-溴苯甲醚;4-溴-2-氯-1-甲氧基苯
英文名称
4-bromo-2-chloro-1-methoxybenzene
英文别名
4-bromo-2-chloroanisole;2-chloro-4-bromoanisole
4-溴-2-氯苯甲醚化学式
CAS
50638-47-6
化学式
C7H6BrClO
mdl
MFCD00128076
分子量
221.481
InChiKey
FPIQNBOUYZLESW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    68.5-70.5°C
  • 沸点:
    242℃
  • 密度:
    1.564
  • 闪点:
    100℃
  • 保留指数:
    1351

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.142
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2909309090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H302
  • 储存条件:
    室温

SDS

SDS:decbe38d80447a2204dca6ce45e37a83
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 4-Bromo-2-chloro-1-methoxybenzene
Synonyms: 4-Bromo-2-chloroanisole

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 4-Bromo-2-chloro-1-methoxybenzene
CAS number: 50638-47-6

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C7H6BrClO
Molecular weight: 221.5

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-溴-2-氯苯甲醚 在 bis-triphenylphosphine-palladium(II) chloride 、 sodium hydroxide磺酰氯 、 sodium hydride 、 碳酸氢钠 作用下, 以 四氢呋喃N-甲基吡咯烷酮二氯甲烷 为溶剂, 生成 3-chloro-6-[2-(3-chloro-4-methoxy-phenyl)-ethyl]-6-cyclopentyl-4-hydroxy-5,6-dihydro-pyran-2-one
    参考文献:
    名称:
    Identification and structure-based optimization of novel dihydropyrones as potent HCV RNA polymerase inhibitors
    摘要:
    A novel class of non-nucleoside HCV NS5B polymerase inhibitors has been identified from screening. A co-crystal structure revealed an allosteric binding site in the protein that required a unique conformational change to accommodate inhibitor binding. Herein we report the structure-activity relationships (SARs) of this novel class of dihydropyrone-containing compounds that show potent inhibitory activities against the HCV RNA polymerase in biochemical assays.
    DOI:
    10.1016/j.bmcl.2006.06.065
  • 作为产物:
    描述:
    2-氯苯甲醚 在 (CH3)4Br 作用下, 以 liquid sulphur dioxide 为溶剂, 以100%的产率得到4-溴-2-氯苯甲醚
    参考文献:
    名称:
    替代亲电香体丹酸酐硫代液。茴香单丁醚替代物的练习曲。过渡与过渡时期的电子通讯
    摘要:
    由苯胺在液体SO 2中的溴化速率常数确定的十一种取代衍生物的反应结构相关性,与在水中观察到的不同,表明该反应对取代基效应高度敏感(ρ= −7.1;ρ= −10.51)。该结果归因于甲氧基的溶剂化,与邻位取代的衍生物(ρ= -8.86)相比,其降低了对位取代的共轭(ρ= -9.70 )。高度溶剂化的过渡态在反应坐标上与反应物相距甚远,在此状态下产生的正电荷几乎为1。
    DOI:
    10.1002/hlca.19830660410
点击查看最新优质反应信息

文献信息

  • [EN] FARNESOID X RECEPTOR AGONISTS AND USES THEREOF<br/>[FR] AGONISTES DU RÉCEPTEUR FARNÉSOÏDE X ET LEURS UTILISATIONS
    申请人:METACRINE INC
    公开号:WO2018170166A1
    公开(公告)日:2018-09-20
    Described herein are compounds that are farnesoid X receptor agonists, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders associated with farnesoid X receptor activity.
    本文描述了一些是法尼索酸X受体激动剂的化合物,制备这类化合物的方法,包含这类化合物的药物组合物和药物,以及使用这类化合物治疗与法尼索酸X受体活性相关的疾病、疾病或紊乱的方法。
  • Ni-Catalyzed Reductive Cyanation of Aryl Halides and Phenol Derivatives via Transnitrilation
    作者:L. Reginald Mills、Joshua M. Graham、Purvish Patel、Sophie A. L. Rousseaux
    DOI:10.1021/jacs.9b11208
    日期:2019.12.11
    reductive coupling for the synthesis of benzonitriles from aryl (pseudo)halides and an electrophilic cyanating reagent, 2-methyl-2-phenyl malononitrile (MPMN). MPMN is a bench-stable, carbon-bound electrophilic CN reagent that does not release cyanide under the reaction conditions. A variety of medicinally relevant benzonitriles can be made in good yields. Addition of NaBr to the reaction mixture allows for
    在此,我们报告了一种 Ni 催化的还原偶联,用于从芳基(伪)卤化物和亲电化试剂 2-甲基-2-苯基丙二腈 (MPMN) 合成苯甲腈。MPMN 是一种工作台稳定的碳键合亲电子 CN 试剂,在反应条件下不会释放化物。可以以良好的收率制备多种与药用相关的苯甲腈。将 NaBr 添加到反应混合物中可以使用更具挑战性的芳基亲电试剂,例如芳基化物、甲苯磺酸盐和三氟甲磺酸盐。机理研究表明,溴化钠在促进这些底物的氧化加成方面发挥作用。
  • Discovery and optimisation of 1-acyl-2-benzylpyrrolidines as potent dual orexin receptor antagonists
    作者:Jodi T. Williams、John Gatfield、Catherine Roch、Alexander Treiber、Francois Jenck、Martin H. Bolli、Christine Brotschi、Thierry Sifferlen、Bibia Heidmann、Christoph Boss
    DOI:10.1039/c5md00074b
    日期:——
    1-acyl-2-benzylpyrrolidines were discovered as potent and competitive dual orexin receptor antagonists. Metabolic stability was improved to afford oral exposure, and aqueous solubility was increased by twentyfold, providing compounds suitable for preclinical evaluation. Compound 27 showed insurmountable antagonism at both orexin 1 and orexin 2 receptor subtypes and displayed a comparable sleep-promoting
    从在大鼠和人肝微粒体中具有高固有清除率和低溶性的噻吩哌啶前导化合物开始,发现了一系列新型的1-酰基-2-苄基吡咯烷酮,它们是有效且具有竞争力的双重orexin受体拮抗剂。改善了代谢稳定性以提供口服暴露,并且溶性增加了二十倍,从而提供了适合临床前评估的化合物。化合物27对orexin 1和orexin 2受体亚型均显示出不可克服的拮抗作用,并且在大鼠中具有与Almorexant和suvorexant相当的促睡眠作用。
  • Mechanistic study on iodine-catalyzed aromatic bromination of aryl ethers by N -Bromosuccinimide
    作者:Pranab Kumar Pramanick、Zhen-Lin Hou、Bo Yao
    DOI:10.1016/j.tet.2017.10.073
    日期:2017.12
    Although iodine-catalyzed reaction has rapid advances in recent years, examples on iodine-catalyzed bromination are rare and the mechanism of these reactions remains unclear. Herein, we reported an I2-catalyzed aromatic bromination of aryl ethers by NBS and presented the details of the mechanistic study including kinetic study and the study of kinetic isotope effects. The study revealed that the reaction
    尽管近年来催化的反应发展迅速,但是催化化的例子很少,这些反应的机理尚不清楚。在本文中,我们报道了NBS的I 2催化的芳基醚的芳族化反应,并详细介绍了包括动力学研究和动力学同位素效应在内的机理研究。研究表明,该反应实际上是由诱导期形成的IBr催化的,而决定速率的步骤是在IBr辅助下消除Wheland中间体的HBr。
  • 2-PYRIDONE COMPOUNDS
    申请人:KAWAGUCHI Takanori
    公开号:US20110237791A1
    公开(公告)日:2011-09-29
    A 2-pyridone compound represented by the formula [1]: wherein in the formula [1], the ring represented by A represents a benzene ring or a pyridine ring, X represents any of the structures represented by the formulas [3] shown below: V represents a single bond or a lower alkylene group, and W represents a single bond, an ether bond or a lower alkylene group (wherein the lower alkylene group may contain an ether bond)}, a tautomer or stereoisomer of the compound, a pharmaceutically acceptable salt thereof, or a solvate thereof is a compound that has an excellent GK activating effect and is useful as a pharmaceutical.
    化学式为[1]所代表的2-吡啶酮化合物: 其中在化学式[1]中, 由A代表苯环或吡啶环表示的环, X代表下面所示的化学式[3]所代表的任意结构: V代表单键或较低的烷基链,以及 W代表单键、醚键或较低的烷基链(其中较低的烷基链可能含有醚键)}, 该化合物的异构体或立体异构体,其药学上可接受的盐,或其溶剂化合物是一种具有出色的GK激活效果并且可用作药物的化合物。
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯